JY
INMB icon

Jeff Yass’s INmune Bio INMB Stock Holding History

Jeff Yass’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.4K Buy
53,000
+35,500
+203% +$49.1K ﹤0.01% 12590
2026
Q1 		$19.8K Sell
17,500
-21,400
-55% -$30.5K ﹤0.01% 12863
2025
Q4 		$60.7K Sell
38,900
-57,300
-60% -$102K ﹤0.01% 11690
2025
Q3 		$199K Sell
96,200
-676,400
-88% -$1.55M ﹤0.01% 10999
2025
Q2 		$1.78M Buy
772,600
+663,300
+607% +$4.87M ﹤0.01% 6041
2025
Q1 		$854K Sell
109,300
-30,500
-22% -$242K ﹤0.01% 7653
2024
Q4 		$653K Sell
139,800
-73,600
-34% -$384K ﹤0.01% 8014
2024
Q3 		$1.15M Buy
213,400
+145,800
+216% +$1.04M ﹤0.01% 6469
2024
Q2 		$596K Buy
67,600
+44,400
+191% +$438K ﹤0.01% 7847
2024
Q1 		$273K Sell
23,200
-12,500
-35% -$151K ﹤0.01% 9918
2023
Q4 		$402K Buy
35,700
+20,800
+140% +$174K ﹤0.01% 9168
2023
Q3 		$102K Sell
14,900
-900
-6% -$7.46K ﹤0.01% 10905
2023
Q2 		$143K Buy
+15,800
New +$127K ﹤0.01% 10619
2023
Q1 		– Sell
-10,100
Closed -$64K – 13012
2022
Q4 		$64K Sell
10,100
-11,500
-53% -$81.6K ﹤0.01% 11259
2022
Q3 		$134K Sell
21,600
-4,900
-18% -$43K ﹤0.01% 11393
2022
Q2 		$234K Buy
+26,500
New +$197K ﹤0.01% 10237
2021
Q4 		– Sell
-41,400
Closed -$804K – 13471
2021
Q3 		$804K Buy
+41,400
New +$799K ﹤0.01% 8117

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Jeff Yass's INMB Position: Q2 2026 in Review

Jeff Yass reduced its INmune Bio (INMB) stake by 18% in Q2 2026, selling an estimated $49.7K and leaving 158,452 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #11379.

Jeff Yass first reported a position in INMB in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.82M in Q1 2024. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Jeff Yass held 158,452 shares of INmune Bio worth $258K as of Q2 2026.
  • Jeff Yass sold 35,939 INmune Bio shares in Q2 2026, an estimated $49.7K.
  • INmune Bio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11379 holding.
  • Jeff Yass first reported a position in INmune Bio in Q1 2020 and has held it in 21 quarters since.
  • Jeff Yass's INmune Bio position peaked at $1.82M in Q1 2024.
  • 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.